The following are earned news media articles, webinars and podcasts with contributions by CHC staff and member interviews and presentations.
Framing DTC Rx Ad Ban and Advertising Tax Deductibility: to convey courts, regulatory and legislative history that a DTC Rx advertising ban would ‘not be easily accomplished, and relate the negative impact that limiting or eliminating the tax deductibility on advertising in year of spend (begun in 1913) would have on the US economy, states and individual congressional districts.
Fierce Pharma Week 2025 – Philadelphia Convention Center (Sept. 8 – 11):
Policy, Politics, and Pharma: Navigating Uncertainty in a High-Stakes Climate
TV Banned: Now What? Future Proofing your Brand in an Uncertain Regulatory Environment
DeepIntent Luncheon: Key Healthcare Marketing Industry Trends, Challenges and Future Opportunities
Health Podcast Summit 2025 (recorded for Oct.1 release, Digital Health Today, Kendall)
Direct-To-Consumer Ads: Manufacturers Face ‘Cease And Desist’ Orders Now, Uncertain Future (Pink Sheet, Sutter)
HHS, FDA drop major DTC advertising policy changes (pharmaphorum, Comstock)
Health Care Policy: Analysis of Potential Policy Outcomes, Industry Effects of MAHA’s Efforts to Target Direct-to-Consumer Pharma Ads (The Capitol Forum, Tracey)
Those annoying pharmaceutical ads have real value (WashPost, Ed Board Opinion)
112-year-old advertising tax deduction survives One Big Beautiful tax bill (Med Ad News, Potter)
Pharma’s ad tax deductibility remains in the crosshairs (MM+M, O’Brien)
Trump floats 200% pharma tariff threat, then teases plan for grace period (MM+M, Bushak)
‘One big beautiful bill’ passes: Here’s what pharma marketers need to know (MM+M, Bushak)
RFK Jr. Plans Crackdown on Pharma Ads and Advertising Tax Deductibility (Bloomberg Health, Zhang)
AMM Forum in NYC: Policy Trends Impacting Medical Media Today (6/12/25 presentation)
Pharma marketing for impact: Where precision, purpose and patients meet (MM+M, Greg James & Chris Paquette)
Taking on the threatened Rx ad ban (Med Ad News, Potter)
Old bill on D2C ad tax breaks meets a new political climate (pharmaphorum, Comstock)
Open Pharma topic meeting: AI laws/regulation update & 4 threats with U.S. research funding, pharma tax deductibility, Rx advertising ban and misinformation (4/28/25 Webinar, CHC YouTube)
FDA commissioner indicates no plans for a DTC Rx advertising ban (SmartBrief)
The Evolving DTC Landscape: Insights, Innovations, & Imperatives for 2025 (DTC National)
RFK Jr.’s HHS gutted OPDP. How will it impact pharma advertising? (MM+M, O’Brien)
Are Bigger Ad Policy Changes Coming After US FDA’s Drug Promotion Office Hit Hard By Layoffs? (Pink Sheet, Sutter)
RFK Jr. May Want To Ban Prescription Drug Ads, But Can He? (Forbes, Cohen)
RFK Jr. has long criticized drug ads. He just slashed the FDA office that regulates them (Endpoints, Brennan & Gelman)
DTC Restrictions & Beyond: Preparing for the Next Wave of Healthcare Policy (POCMA Summit 2025)
Talking DTC: What Does the New Administration Mean for DTC Marketing? (DCT Perspectives webinar, Jim Potter & Jay Carter)
Prepared, not panicked: Leaders await RFK Jr.’s potential TV pharma ad ban (MM+M, O’Brien)
Trump and RFK promised to ban D2C pharma advertising. Pharma is ready for a fight (pharmaphorum, Comstock)
Can RFK Jr. ban pharma TV ads? (Politico, Gardner & Lim)
A look at the tax benefits for pharma ads (Politico, Gardner & Lim)
Will pharma’s loyalty to linear TV begin to fade in 2025? (MM+M, Iskowitz)
RFK Plans to Take on Big Pharma. It’s Easier Said Than Done (WIRED, Mullin)
Can Trump 2.0 administration cancel pharma marketers’ $5 billion TV ad spending? (M&P, Bilek)
Robert F. Kennedy Jr. Wants to Ban Drug Ads on TV. It Wouldn’t Be Easy (NYTimes, Robbins)
Will Trump try to outlaw TV drug ads? (MM+M podcast, Bushak)
RFK Jr.’s step-by-step blueprint to question the safety of vaccines (STAT, Zhang & Owermohle)
RFK Jr. & Elon Musk want to ban pharma ads. They wouldn’t be the first to try (Endpoints, Gelman)
Carr Raises Prospect of Pharma Ad Ban, Would Face 1st Amendment Challenges (Comms Daily, Tayloe)
RFK Jr.’s plan for pharma ads would run straight into the First Amendment (MSNBC, Levison)
RFK Jr.’s push to BAN direct-to-consumer pharma ads sparks industry anxiety and legal debate (NEWSTARGET, Hughes)
What RFK Jr.’s Dislike for Drug TV Commercials Could Mean for the Ad Industry (WSJ, Graham)
Healthcare Marketing
Private equity and the evolution of medical marketing (Med Ad News, Jay Carter)
Healthcare Agency Roundtable 2024: Moving into 2025 (Med Ad News, Jeff Berg, Eric Densmore, Jay Carter, Mike Myers, Angula Tenuta)
Health Data Privacy
Recap of new state health data privacy laws (Med Ad News, Potter)
Regulatory
FTC revised Health Breach Notification Rule now in effect (Med Ad News, Potter)
FDA’s final rule impact on direct-to-consumer prescription drug ads (Med Ad News, Potter)
Healthcare Marketing Legislation
Health care in December’s lame duck Congress (Med Ad News, Potter)
About Coalition for Healthcare Communication
Founded in 1993, the Coalition of Healthcare Communication, a subsidiary of 4As, promotes the free exchange of accurate, credible, and scientifically sound healthcare information. The CHC is the trade association representing and advocating for healthcare marketing, publishing and advertising technology companies. The CHC works to ensure that healthcare communicators have a seat at the table when important decisions are being made impacting the free flow of important and truthful healthcare communications.
For further information, please contact Jim Potter, CHC Executive Director at [email protected].
